Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Activity
RulesProposed and final rules open for commentGrantsFederal funding opportunities and deadlinesPress releasesWhat agencies are announcing publiclyHearingsCongressional committee hearings and meetingsBillsLegislation, actions, amendments, and votes
Views
AgenciesEverything from a single federal agencyTopicsActivity grouped by policy areaOrganizationsCompanies, associations, and advocacy groupsCommitteesHouse, Senate, and joint committee activityLegislatorsMembers of Congress, service, bills, and votes
Pricing
LoginCreate account

Table of contents

DetailsRelated

Tab 11 - Osborne

FDA-2026-P-8647-0013Supporting & Related Material
Document

Details

The document's own metadata, straight from the source system.

Title
Tab 11 - Osborne
Posted
Aug 6, 2026
Agency
Food and Drug Administration (FDA)
Topics
  • Banking Regulation
  • Biomedical Research
  • Government Oversight & Accountability
  • Healthcare Costs & Access
  • Higher Education
  • Medicare & Medicaid
  • Pharmaceutical Policy
View on regulations.gov ↗
Related

Related documents

Other documents filed with this rulemaking.

View related documents
Supporting & Related Material
Tab 16 - Impoyz Clin Pharm Review (excerpt)
No comment periodAug 6, 2026
Supporting & Related Material
Tab 15 - MedPharm Study Data - Confidential
No comment periodAug 6, 2026
Supporting & Related Material
Tab 18 - Q3 Guidance
No comment periodAug 6, 2026
Supporting & Related Material
Tab 19 - IVPT Draft Guidance (excerpt)
No comment periodAug 6, 2026
Supporting & Related Material
Tab 25 - Desonate Meeting Minutes
No comment periodAug 6, 2026
Supporting & Related Material
Tab 54 - CP Study Plan - Confidential
No comment periodAug 6, 2026
Supporting & Related Material
Tab 3 - Notice Letter (excerpt)
No comment periodAug 6, 2026
Other
Acknowledgement Letter from FDA DMB to Primus Pharmaceuticals, Inc.
No comment periodAug 6, 2026

On this page

DetailsRelated
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ActivityRulesGrantsPress releases
ViewsAgenciesTopicsOrganizations
GuidesInstall Government ContextFive questions to ask your agentAll guides
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.